Carfilzomib

Tags: Drug.

Carfilzomib (abbreviated CFZ marketed under the trade name Kyprolis Onyx Pharmaceuticals Inc.) is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically it is a tetrapeptide epoxyketone and an analog of epoxomicin.The U.S.

thumbnail

ATC prefix

L01

ATC suffix

XX45

CAS number

868540-17-4

IUPAC name

(S)-4-Methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide

PubChem

11556711